Cargando…
Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells
Among cells of the immune system, CD11c(+) and DEC-205(+) splenic dendritic cells primarily express the cellular receptor (α-dystroglycan [α-DG]) for lymphocytic choriomeningitis virus (LCMV). By selection, strains and variants of LCMV that bind α-DG with high affinity are associated with virus repl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193355/ https://www.ncbi.nlm.nih.gov/pubmed/11067874 |
_version_ | 1782147451345436672 |
---|---|
author | Sevilla, Noemí Kunz, Stefan Holz, Andreas Lewicki, Hanna Homann, Dirk Yamada, Hiroki Campbell, Kevin P. de la Torre, Juan C. Oldstone, Michael B.A. |
author_facet | Sevilla, Noemí Kunz, Stefan Holz, Andreas Lewicki, Hanna Homann, Dirk Yamada, Hiroki Campbell, Kevin P. de la Torre, Juan C. Oldstone, Michael B.A. |
author_sort | Sevilla, Noemí |
collection | PubMed |
description | Among cells of the immune system, CD11c(+) and DEC-205(+) splenic dendritic cells primarily express the cellular receptor (α-dystroglycan [α-DG]) for lymphocytic choriomeningitis virus (LCMV). By selection, strains and variants of LCMV that bind α-DG with high affinity are associated with virus replication in the white pulp, show preferential replication in a majority of CD11c(+) and DEC-205(+) cells, cause immunosuppression, and establish a persistent infection. In contrast, viral strains and variants that bind with low affinity to α-DG are associated with viral replication in the red pulp, display minimal replication in CD11c(+) and DEC-205(+) cells, and generate a robust anti-LCMV cytotoxic T lymphocyte response that clears the virus infection. Differences in binding affinities can be mapped to a single amino acid change in the viral glycoprotein 1 ligand that binds to α-DG. These findings indicate that receptor–virus interaction on dendritic cells in vivo can be an essential step in the initiation of virus-induced immunosuppression and viral persistence. |
format | Text |
id | pubmed-2193355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21933552008-04-16 Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells Sevilla, Noemí Kunz, Stefan Holz, Andreas Lewicki, Hanna Homann, Dirk Yamada, Hiroki Campbell, Kevin P. de la Torre, Juan C. Oldstone, Michael B.A. J Exp Med Original Article Among cells of the immune system, CD11c(+) and DEC-205(+) splenic dendritic cells primarily express the cellular receptor (α-dystroglycan [α-DG]) for lymphocytic choriomeningitis virus (LCMV). By selection, strains and variants of LCMV that bind α-DG with high affinity are associated with virus replication in the white pulp, show preferential replication in a majority of CD11c(+) and DEC-205(+) cells, cause immunosuppression, and establish a persistent infection. In contrast, viral strains and variants that bind with low affinity to α-DG are associated with viral replication in the red pulp, display minimal replication in CD11c(+) and DEC-205(+) cells, and generate a robust anti-LCMV cytotoxic T lymphocyte response that clears the virus infection. Differences in binding affinities can be mapped to a single amino acid change in the viral glycoprotein 1 ligand that binds to α-DG. These findings indicate that receptor–virus interaction on dendritic cells in vivo can be an essential step in the initiation of virus-induced immunosuppression and viral persistence. The Rockefeller University Press 2000-11-06 /pmc/articles/PMC2193355/ /pubmed/11067874 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Original Article Sevilla, Noemí Kunz, Stefan Holz, Andreas Lewicki, Hanna Homann, Dirk Yamada, Hiroki Campbell, Kevin P. de la Torre, Juan C. Oldstone, Michael B.A. Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells |
title | Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells |
title_full | Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells |
title_fullStr | Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells |
title_full_unstemmed | Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells |
title_short | Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells |
title_sort | immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193355/ https://www.ncbi.nlm.nih.gov/pubmed/11067874 |
work_keys_str_mv | AT sevillanoemi immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT kunzstefan immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT holzandreas immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT lewickihanna immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT homanndirk immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT yamadahiroki immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT campbellkevinp immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT delatorrejuanc immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells AT oldstonemichaelba immunosuppressionandresultantviralpersistencebyspecificviraltargetingofdendriticcells |